Literature DB >> 698136

Urinary kallikrein activity of workers exposed to lead.

P Boscolo, G Porcelli, G Cecchetti, E Salimei, A Iannaccone.   

Abstract

Two groups of men of different age ranges and with the same period of lead exposure were selected for study in a recently opened car-battery factory. Two other groups of age-matched men, not exposed to heavy metals in their work, were used as controls. Morning urines were collected from control and exposed groups for determination of urinary kallikrein activity, urinary delta-amino-levulinic acid (ALA) and lead levels. The environmental lead levels and the urinary ALA and lead values indicated that exposure in the factory was not heavy. The older group of lead-exposed workers showed greatly reduced urinary kallikrein activity compared with that of the age-matched controls. In contrast, the younger group did not show any significant alteration in urinary kallikrein excretion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 698136      PMCID: PMC1008409          DOI: 10.1136/oem.35.3.226

Source DB:  PubMed          Journal:  Br J Ind Med        ISSN: 0007-1072


  23 in total

1.  A FOLLOW-UP STUDY OF LEAD WORKERS.

Authors:  I DINGWALL-FORDYCE; R E LANE
Journal:  Br J Ind Med       Date:  1963-10

2.  Effects of environmental lead levels on the urinary kallikrein excretion of exposed workers.

Authors:  P Boscolo; E Salimei; A Adamo; G Porcelli
Journal:  Life Sci       Date:  1977-05-15       Impact factor: 5.037

3.  [Enzymatic and ultrastructural changes in the kidneys of rats poisoned over a long period of time with low doses of lead].

Authors:  P Boscolo; G Sacchettoni Logroscino; G Bombardieri
Journal:  Med Lav       Date:  1977 Mar-Apr       Impact factor: 1.275

4.  Proceedings: Kininogenase activity in urine and perfusion fluid of isolated rat kidney.

Authors:  J S Roblero; H R Croxatto; J H Corthorn; R L García; E De Vito
Journal:  Acta Physiol Lat Am       Date:  1973

5.  Urinary kallikrein excretion in hypertensive man. Relationships to sodium intake and sodium-retaining steroids.

Authors:  H S Margolius; D Horwitz; J J Pisano; H R Keiser
Journal:  Circ Res       Date:  1974-12       Impact factor: 17.367

6.  Delta-aminolevulinate dehydratase, a zinc dependent enzyme.

Authors:  V N Finelli; L Murthy; W B Peirano; H G Petering
Journal:  Biochem Biophys Res Commun       Date:  1974-10-23       Impact factor: 3.575

7.  [Arterial hypertension and urinary kallikrein].

Authors:  A V Greco; G Porcelli; H R Croxatio; G Fedeli; G Ghirlanda
Journal:  Minerva Med       Date:  1974-08-18       Impact factor: 4.806

8.  Lead intoxication: its effect on the renin-aldosterone response to sodium deprivation.

Authors:  H H Sandstead; A M Michelakis; T E Temple
Journal:  Arch Environ Health       Date:  1970-03

9.  [Urinary kallikrein and risk of lead poisoning].

Authors:  A Iannaccone; G Porcelli; P Boscolo
Journal:  Ann Ist Super Sanita       Date:  1977       Impact factor: 1.663

10.  [Determination of urinary lead through optic emission spectrography using the double-arch method].

Authors:  G Cecchetti; A Iannoccone
Journal:  Ann Ist Super Sanita       Date:  1977       Impact factor: 1.663

View more
  4 in total

1.  Urinary kallikrein activity in workers exposed to cadmium, lead, or mercury vapour.

Authors:  H A Roels; R R Lauwerys; J P Buchet; A M Bernard; P Lijnen; G Van Houte
Journal:  Br J Ind Med       Date:  1990-05

2.  Markers of early renal changes induced by industrial pollutants. II. Application to workers exposed to lead.

Authors:  A Cárdenas; H Roels; A M Bernard; R Barbon; J P Buchet; R R Lauwerys; J Roselló; I Ramis; A Mutti; I Franchini
Journal:  Br J Ind Med       Date:  1993-01

Review 3.  Chronic low-level lead exposure. Its role in the pathogenesis of hypertension.

Authors:  D S Sharp; C E Becker; A H Smith
Journal:  Med Toxicol       Date:  1987 May-Jun

4.  Neurohumoral blood pressure regulation in lead exposure.

Authors:  P Boscolo; M Carmignani
Journal:  Environ Health Perspect       Date:  1988-06       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.